Search - tctmd.com

Displaying 41 - 60 of 146

Sort: Relevancy | Date

News Daily News

Hemodiafiltration Lowers Mortality in ACS Patients With Renal, Cardiac Dysfunction

November 06, 2014

Presentation TCT 2014

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Graham A. Cassel

September 16, 2014

Presentation TCT 2014

Access Site and the Risk of Acute Kidney Injury

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Hitinder S. Gurm

September 16, 2014

Presentation TCT 2014

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Intravenous and Oral Hydration to Prevent Contrast Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Carlo Briguori

September 16, 2014

News Conference News TCT 2014

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

September 16, 2014

News Conference News TCT 2014

NAC, Sodium Bicarbonate Combo Fails to Improve Renal Protection in High-Risk Patients

September 14, 2014

Presentation TCT 2014

CONTRAST: A Prospective, Randomized Trial of N-Acetylcysteine Versus Sodium Bicarbonate Versus N-Acetylcysteine Plus Sodium Bicarbonate in Patients at Risk for Contrast Nephropathy

Presenter: Patrick W. Serruys, Huay Cheem Tan

September 13, 2014

News Daily News

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

September 11, 2014

News Conference News ESC 2014

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

Caitlin E. Cox

September 01, 2014

News Daily News

早期高剂量瑞伐他汀并不能对NSTE-ACS患者提供心肌保护

Yael L. Maxwell

August 20, 2014

News Daily News

Una Dosis Alta Inicial de Rosuvastatina No Ofrece Protección Miocárdica en los SCASEST

Yael L. Maxwell

August 20, 2014

News Daily News

Early High-Dose Rosuvastatin Does Not Provide Myocardial Protection in NSTE-ACS

Yael L. Maxwell

August 20, 2014

News Daily News

地区性的质量改进努力降低了PCI后造影剂所致AKI

Yael L. Maxwell

August 07, 2014

News Daily News

Regional Quality-Improvement Effort Reduces Contrast-Induced AKI After PCI

Yael L. Maxwell

August 07, 2014

News Daily News

El Intento Regional de Mejora de la Calidad Reduce la LRA Inducida por Contraste Post-PCI

Yael L. Maxwell

August 07, 2014

News Daily News

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

May 30, 2014

News Daily News

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

May 30, 2014

News Daily News

NAC and/or Sodium Bicarbonate Fail to Add Protection Against Acute Kidney Damage in STEMI

Yael L. Maxwell

April 15, 2014

Advertisement

Hemodiafiltration Lowers Mortality in ACS Patients With Renal, Cardiac Dysfunction

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Access Site and the Risk of Acute Kidney Injury

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Clinical Trial Updates: RenalGuard, AVERT, etc.

Intravenous and Oral Hydration to Prevent Contrast Nephropathy

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

NAC, Sodium Bicarbonate Combo Fails to Improve Renal Protection in High-Risk Patients

CONTRAST: A Prospective, Randomized Trial of N-Acetylcysteine Versus Sodium Bicarbonate Versus N-Acetylcysteine Plus Sodium Bicarbonate in Patients at Risk for Contrast Nephropathy

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

早期高剂量瑞伐他汀并不能对NSTE-ACS患者提供心肌保护

Una Dosis Alta Inicial de Rosuvastatina No Ofrece Protección Miocárdica en los SCASEST

Early High-Dose Rosuvastatin Does Not Provide Myocardial Protection in NSTE-ACS

地区性的质量改进努力降低了PCI后造影剂所致AKI

Regional Quality-Improvement Effort Reduces Contrast-Induced AKI After PCI

El Intento Regional de Mejora de la Calidad Reduce la LRA Inducida por Contraste Post-PCI

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

NAC and/or Sodium Bicarbonate Fail to Add Protection Against Acute Kidney Damage in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content